I am a dynamic, results-oriented Medtech CEO, Managing Director, and Non-Executive Director with over 25 years of executive and board-level experience across Asia Pacific, spanning private and publicly listed companies. My expertise covers medical devices, biotech, and diagnostics, including heart failure, transplants, mechanical circulatory support, cardiac rhythm management, interventional cardiology, ophthalmology, and wearable and diagnostic technologies.
I have consistently delivered high-growth outcomes, taking three companies from $0 to $20M+ revenue within two years and managing revenues exceeding $50M. I’ve secured regulatory approvals and reimbursement for first-in-class technologies across the U.S., Asia Pacific, Japan, China, and India, including FDA breakthrough designation. I’ve also led capital raises exceeding $30M and taken companies public on ASX and NASDAQ.
At board level, I drive profitable growth through strong governance, commercialization strategy, and leadership, with over 16 years’ experience in remuneration and audit committees delivering sustained performance and compliance.
